Cavan M. Redmond - 24 Jun 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Director
Signature
/s/ Cavan M. Redmond
Issuer symbol
OCX
Transactions as of
24 Jun 2022
Net transactions value
$0
Form type
4
Filing time
19 Jul 2022, 16:05:42 UTC
Previous filing
16 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Options Exercise $0 +10,000 +9% $0.000000 120,863 24 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Restricted Stock Units Options Exercise $0 -10,000 -100% $0.000000* 0 24 Jun 2022 Common Stock 10,000 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units vested on June 24, 2022.